Head-to-head · WeighScore
Gala Health vs Vitalex Health
The verdict
Gala Health takes it — 82.9/100 to 59.7/100.
Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A compounded tirzepatide and semaglutide program for women that reaches all 50 states and keeps a brand-name Ozempic path open — but its $179 and $149 headline rates are yearly-subscription prices, not monthly ones.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Gala Health | Vitalex Health |
|---|---|---|
| WeighScore | 82.9/100 | 59.7/100 |
| Grade | B− | C |
| Scorecard rank | #17 | #337 |
| Semaglutide | Not disclosed | $199/mo (starting dose, compounded) |
| Tirzepatide | $179/mo (yearly subscription) | $199/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #17 · B−
Strengths
- Low compounded entry if you prepay the year — $179/mo tirzepatide and $149/mo microdose on the yearly subscription, $199/mo on a 3-month plan
- Prices are published openly rather than quiz-gated, with all doses included at the one rate
- All 50 states and LegitScript-verified, with a brand-name Ozempic path kept open ($1,299)
- HRT and menopause care available alongside GLP-1
Where it loses points
- No month-to-month price is published anywhere — the $179 tirzepatide and $149 microdose rates are both yearly subscriptions, and the shortest term Gala names is a 3-month plan at $199/mo
- Compounded formulations are not FDA-approved
- Brand-name Ozempic is priced steeply at $1,299
- No oral or sublingual route offered yet — injection only
- Newer operator (Gala GLP-1 by AI Coaching Inc) with no named clinicians and no named dispensing pharmacy
Graded #337 · C
Strengths
- Flat-rate pricing starting at $199/mo with no consultation fee or dose-change surcharges
- Three distinct programs — Semaglutide, Tirzepatide, and a lower-dose GLP-1 Microdose protocol for body composition
- Names its legal entity (Vitalex Health, LLC), a real street address, phone number, and posted clinical hours
- Named lead clinician (Laqueta Nelson, MSN, FNP-BC) instead of an anonymous care team
- Working Terms of Service, Privacy Policy, and HIPAA Notice pages, not dead links
Where it loses points
- Brands itself “physician-led” sitewide, but the only named clinician is a nurse practitioner (FNP-BC), not a physician
- No LegitScript seal or other third-party pharmacy-verification badge found anywhere on the site
- Compounding pharmacy and prescribing medical group are referenced only generically — neither is named
- Exact price is not published — the $199/mo figure is only a starting point confirmed after provider review
- Domain was registered in April 2026 — a brand-new practice with no independent reviews found
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.